13-23889281-C-T

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_005932.4(MIPEP):​c.40G>A​(p.Ala14Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000811 in 1,374,058 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00074 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00082 ( 3 hom. )

Consequence

MIPEP
NM_005932.4 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: -0.782
Variant links:
Genes affected
MIPEP (HGNC:7104): (mitochondrial intermediate peptidase) The product of this gene performs the final step in processing a specific class of nuclear-encoded proteins targeted to the mitochondrial matrix or inner membrane. This protein is primarily involved in the maturation of oxidative phosphorylation (OXPHOS)-related proteins. This gene may contribute to the functional effects of frataxin deficiency and the clinical manifestations of Friedreich ataxia. [provided by RefSeq, Jul 2008]
PCOTH (HGNC:39839): (prostate and testis expressed opposite C1QTNF9B and MIPEP) Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0056168735).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000742 (113/152356) while in subpopulation NFE AF= 0.00138 (94/68024). AF 95% confidence interval is 0.00116. There are 0 homozygotes in gnomad4. There are 52 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MIPEPNM_005932.4 linkc.40G>A p.Ala14Thr missense_variant 1/19 ENST00000382172.4 NP_005923.3 Q99797

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MIPEPENST00000382172.4 linkc.40G>A p.Ala14Thr missense_variant 1/191 NM_005932.4 ENSP00000371607.3 Q99797
PCOTHENST00000382133.9 linkn.170+270C>T intron_variant 1
MIPEPENST00000469167.1 linkn.118G>A non_coding_transcript_exon_variant 1/35

Frequencies

GnomAD3 genomes
AF:
0.000749
AC:
114
AN:
152238
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00138
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000398
AC:
6
AN:
15070
Hom.:
0
AF XY:
0.000515
AC XY:
4
AN XY:
7774
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000583
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00139
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000820
AC:
1002
AN:
1221702
Hom.:
3
Cov.:
30
AF XY:
0.000800
AC XY:
473
AN XY:
591092
show subpopulations
Gnomad4 AFR exome
AF:
0.000296
Gnomad4 AMR exome
AF:
0.000962
Gnomad4 ASJ exome
AF:
0.000117
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00109
Gnomad4 FIN exome
AF:
0.0000249
Gnomad4 NFE exome
AF:
0.000853
Gnomad4 OTH exome
AF:
0.000625
GnomAD4 genome
AF:
0.000742
AC:
113
AN:
152356
Hom.:
0
Cov.:
32
AF XY:
0.000698
AC XY:
52
AN XY:
74504
show subpopulations
Gnomad4 AFR
AF:
0.000168
Gnomad4 AMR
AF:
0.000392
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.00138
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000794
Hom.:
0
Bravo
AF:
0.000759
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000158
AC:
1
ExAC
AF:
0.000141
AC:
5

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsJan 16, 2020This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsApr 09, 2024- -
not provided Uncertain:2
Uncertain significance, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 14 of the MIPEP protein (p.Ala14Thr). This variant is present in population databases (rs367730807, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with MIPEP-related conditions. ClinVar contains an entry for this variant (Variation ID: 1030040). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Not Available"; Align-GVGD: "Not Available". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJan 24, 2024This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
8.2
DANN
Uncertain
0.99
DEOGEN2
Benign
0.028
T
Eigen
Benign
-0.95
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.052
N
LIST_S2
Benign
0.68
T
M_CAP
Benign
0.0039
T
MetaRNN
Benign
0.0056
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.90
L
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-0.12
N
REVEL
Benign
0.037
Sift
Benign
0.11
T
Sift4G
Benign
0.26
T
Polyphen
0.012
B
Vest4
0.27
MVP
0.067
MPC
0.087
ClinPred
0.068
T
GERP RS
2.8
Varity_R
0.037
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs367730807; hg19: chr13-24463420; API